Posted by Michael Wonder on 28 Jul 2025
Dupilumab for the treatment of adults with severe chronic rhinosinusitis with nasal polyps (review of TA648)
23 July 2025 - The Department of Health and Social Care has asked NICE to produce guidance on the use of dupilumab in the NHS in England.
For the time being, dupilumab should not be used as an add-on to intranasal corticosteroids for the treatment of adults with severe chronic rhinosinusitis with nasal polyps that is not controlled well enough by systemic corticosteroids or surgery.
